Keyphrases
Chronic Lymphocytic Leukemia
85%
Ibrutinib
46%
Chronic Lymphocytic Leukemia Cells
33%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
28%
BCR Signaling
19%
Nurse-like Cells
18%
Programmed Death-ligand 1 (PD-L1)
16%
T Follicular Helper Cells
14%
Spleen Tyrosine Kinase
14%
Level Function
14%
Pre-BCR
14%
B-cell Inhibition
14%
CXCL13
14%
Forkhead Box O1 (FOXO1)
14%
Disease Activity
14%
Lenalidomide
14%
AKT1
14%
Plasma Parameters
14%
Regulatory B Cells
14%
Cell Co-culture
14%
β-cell Function
14%
Rituximab
14%
Signal Transducer and Activator of Transcription 3
14%
B Lymphocytes
14%
Leukemia Progression
14%
Cancer Gene mutations
14%
Randomized Trial
14%
Precursor B-cell Acute Lymphoblastic Leukemia
14%
Tyrosine Kinase Inhibition
14%
Leukemia Microenvironment
14%
Water Labelling
14%
Precursor B-cell
14%
Leukemia Patients
11%
B-cell Receptor Signaling
11%
Progression-free Survival
10%
TP53 mutation
8%
Plasma Concentration
7%
BCL6
7%
Complex Karyotype
7%
Del17p
7%
T Cell Subsets
7%
Overall Survival
7%
Lymph Node Microenvironment
6%
CCL3
6%
Chemokine Secretion
6%
B Cell Receptor
5%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Ibrutinib
47%
Leukemia Cell
39%
B Lymphocyte Receptor
22%
B Cell
17%
Neoplasm
15%
Cell Function
14%
Protein Kinase Syk
14%
Programmed Death-Ligand 1
14%
Biological Marker
14%
Immunosuppressive Drug
14%
Tumor Gene
14%
Transcription Factor
14%
STAT3 Protein
14%
Janus Kinase 1
14%
Venetoclax
14%
Rituximab
14%
Precursor
14%
Acute B-Cell Lymphoblastic Leukemia
14%
Lenalidomide
14%
Disease Activity
14%
Regulatory B Cell
14%
Deuterium Oxide
14%
Cell Kinetics
14%
IGHV@
14%
Protein Kinase ZAP 70
14%
Diseases
12%
Progression Free Survival
10%
Overall Survival
7%
Karyotype
7%
Minimal Residual Disease
6%
B-Cell Lymphoma
5%
Alternative Complement Pathway C3 C5 Convertase
5%
Nuclear Factor
5%
Immunology and Microbiology
Leukemia Cell
44%
B Cell
20%
Follicular B Helper T Cells
14%
Immunoglobulin D
14%
Immunosuppressive Drug
14%
Blood Level
14%
Rituximab
14%
Tumor Gene
14%
Immunoglobulin M
14%
Cyclophosphamide
14%
Regulatory B Cells
14%
Cell Function
14%
Lenalidomide
14%
Programmed Death-Ligand 1
14%
STAT3
14%
CXCL13
14%
Immunotherapy
14%
Coculture
14%
Lymph Node
12%
Downregulation
11%
Karyotype
10%
Regulatory T Cell
10%
T Cell Subset
10%
Overall Survival
10%
Progression Free Survival
10%
Bruton Tyrosine Kinase
10%
Isotype
8%
BCL6
7%
Immune Tolerance
7%
T Cell Receptor
7%
T-Helper Cell
7%
Secretion (Process)
6%